4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-24-000037
Director sold 3,208 shares at $19.43 ($62,331)
From the SEC's structured data for this filing
Trades in this filing
Krognes Steve E. · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-05 | Sale : show line 1 in the form | −3,208 | $19.43 | $62,331 | 142,591 | D |
| Open-market sales · 3,208 sh · avg $19.43 · $62,331 | ||||||
Loading xslF345X05/wk-form4_1704846873.xml…